News from
Science, Economy
and the BIO.NRW network
News
BIO.NRW and ZENIT GmbH in cooperation – The new brochure of selected funding tools for the life sciences is now available
At the end of April this year, the European Parliament finally approved the legislative texts for the EU's new research framework program "Horizon Europe". The work programs in the individual funding areas ...
Weiterlesen …
Weiterlesen …
Publication of the Work Program 2021-2022 of the Horizon Europe Cluster Health
The EU Commission has published the Horizon Europe work program in cluster 1. Among other things, this contains the calls for proposals for the health sector in 2021 and 2022. The Health ...
Weiterlesen …
Weiterlesen …
2021 Medical Technologies and Digital Health Matchmaking Meeting, Wuhan, Hubei Province
On June 24, 2021, BIO CM participated in the 2021 Medical Technologies and Digital Health Matchmaking Meeting. BIO CM was invited to this event by the Wuhan National Bioindustry Base / Biolake, ...
Weiterlesen …
Weiterlesen …
Even faster towards fermentative RNA production
Our work on the fermentative production of RNA-based active ingredients is funded by the German Federal Ministry of Education and Research. The governmental grant complements a VC-backed RnD budget to further develop ...
Weiterlesen …
Weiterlesen …
Catalent to Acquire RheinCell Therapeutics
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it has reached an agreement ...
Weiterlesen …
Weiterlesen …
Publication of the Work Program 2021-2022 of the Horizon Europe Cluster 6 “Food, Bioeconomy, Natural Resources, Agriculture and Environment”
The EU Commission has published the Horizon Europe work program in cluster 6. Among other things, this contains the calls for proposals for the bioeconomy sector in 2021 and 2022. Depending on ...
Weiterlesen …
Weiterlesen …
Evonik and Stanford University sign research collaboration: Evonik to market and develop new drug delivery platform for mRNA and gene therapy
Evonik is working with Stanford University on a technology to deliver mRNA to tissues and organs that goes beyond the capabilities of lipid nanoparticles (LNPs). This polymer-based platform complements Evonik’s existing portfolio ...
Weiterlesen …
Weiterlesen …
Stay tuned: BIO.NRW.eco events in the second half of the year
The focus area BIO.NRW.eco starts the second half of the year with a series of exciting events. Look forward to webinars on diverse topics from the large field of bioeconomy. Below you ...
Weiterlesen …
Weiterlesen …
News archive
BIO.NRW and ZENIT GmbH in cooperation – The new brochure of selected funding tools for the life sciences is now available
At the end of April this year, the European Parliament finally approved the legislative texts for the EU's new research ...
Weiterlesen …
Weiterlesen …
Publication of the Work Program 2021-2022 of the Horizon Europe Cluster Health
The EU Commission has published the Horizon Europe work program in cluster 1. Among other things, this contains the calls ...
Weiterlesen …
Weiterlesen …
2021 Medical Technologies and Digital Health Matchmaking Meeting, Wuhan, Hubei Province
On June 24, 2021, BIO CM participated in the 2021 Medical Technologies and Digital Health Matchmaking Meeting. BIO CM was ...
Weiterlesen …
Weiterlesen …
Fast SARS-CoV-2 RNA extraction for high-throughput
BioEcho developed a rapid extraction protocol that reduces the isolation of SARS-CoV-2-RNA to just a few minutes. The speed of ...
Weiterlesen …
Weiterlesen …
Bioeconomy now with more visibility on our BIO.NRW homepage!
Definitions, backgrounds, specific funding tools and relevance for NR is discussed. The bioeconomy now has its own tab on the ...
Weiterlesen …
Weiterlesen …
New Bioeconomy Council convenes for its constituent meeting
The Federal Ministry of Education and Research (BMBF) and the Federal Ministry of Food and Agriculture (BMEL) have appointed the ...
Weiterlesen …
Weiterlesen …
AiCuris receives approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany
The Compassionate Use Program (CUP) may provide access to pritelivir for use in immunocompromised patients that have acyclovir-resistant mucocutaneous herpes ...
Weiterlesen …
Weiterlesen …
EuropaBio Webinar: The European Commission’s Toolbox for Biotech SMEs & Start-Ups
The Webinare is part of a series by EuropaBio on "How does the EU support small – and medium sized ...
Weiterlesen …
Weiterlesen …
No posts found.
No posts found.
No posts found.